Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

France Grants an Approval to Baclofen for Alcohol Dependence.

Rolland B, Simon N, Franchitto N, Aubin HJ.

Alcohol Alcohol. 2019 Nov 25. pii: agz082. doi: 10.1093/alcalc/agz082. [Epub ahead of print] No abstract available.

PMID:
31761949
2.

Alcohol Use Disorder Is Differently Associated With Psychotic Symptoms According To Underlying Psychiatric Disorders: A General Population Study.

Pignon B, Sescousse G, Amad A, Benradia I, Vaiva G, Thomas P, Geoffroy PA, Roelandt JL, Rolland B.

Alcohol Alcohol. 2019 Oct 11. pii: agz077. doi: 10.1093/alcalc/agz077. [Epub ahead of print]

PMID:
31603188
3.

Untreated alcohol use disorder in people who inject drugs (PWID) in France: a major barrier to HCV treatment uptake (the ANRS-FANTASIO study).

Barré T, Marcellin F, Di Beo V, Delorme J, Rojas Rojas T, Mathurin P, Protopopescu C, Bailly F, Coste M, Authier N, Carrieri MP, Rolland B.

Addiction. 2019 Oct 8. doi: 10.1111/add.14820. [Epub ahead of print]

PMID:
31595554
4.

Tobacco Treatment Program Implementation at NCI Cancer Centers: Progress of the NCI Cancer Moonshot-Funded Cancer Center Cessation Initiative.

D'Angelo H, Rolland B, Adsit R, Baker TB, Rosenblum M, Pauk D, Morgan GD, Fiore MC.

Cancer Prev Res (Phila). 2019 Nov;12(11):735-740. doi: 10.1158/1940-6207.CAPR-19-0182. Epub 2019 Sep 3.

PMID:
31481540
5.

Addressing Challenges in Converting Grant-Funded Infrastructures to Broadly Used Research Resources.

Rolland B, Geiger AM.

Cancer Epidemiol Biomarkers Prev. 2019 Oct;28(10):1559-1562. doi: 10.1158/1055-9965.EPI-19-0043. Epub 2019 Aug 28.

PMID:
31462397
6.

France removes hepatitis C treatment prescriber restrictions-But what is the impact of the delay for key populations?

Marcellin F, Roux P, Lazarus JV, Rolland B, Carrieri P.

Liver Int. 2019 Dec;39(12):2418-2419. doi: 10.1111/liv.14208. Epub 2019 Aug 22. No abstract available.

PMID:
31436366
7.

What place for prolonged-release buprenorphine depot-formulation Buvidal® in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine.

Vorspan F, Hjelmström P, Simon N, Benyamina A, Dervaux A, Brousse G, Jamain T, Kosim M, Rolland B.

Expert Opin Drug Deliv. 2019 Sep;16(9):907-914. doi: 10.1080/17425247.2019.1649252. Epub 2019 Aug 23.

PMID:
31364884
8.

Dose-dependent metabolite changes after ethanol intoxication in rat prefrontal cortex using in vivo magnetic resonance spectroscopy.

Carton L, Auger F, Kyheng M, Pétrault M, Durieux N, Allorge D, Cottencin O, Jardri R, Bordet R, Rolland B.

Sci Rep. 2019 Jul 23;9(1):10682. doi: 10.1038/s41598-019-47187-4.

9.

A capture-recapture method for estimating the incidence of off-label prescriptions: the example of baclofen for alcohol use disorder in France.

Auffret M, Rolland B, Béhal H, Labreuche J, Jouanjus E, Bordet R, Gautier S.

Therapie. 2019 Dec;74(6):645-650. doi: 10.1016/j.therap.2019.06.002. Epub 2019 Jun 20.

PMID:
31277890
10.

Therapeutic Prospects of Cannabidiol for Alcohol Use Disorder and Alcohol-Related Damages on the Liver and the Brain.

De Ternay J, Naassila M, Nourredine M, Louvet A, Bailly F, Sescousse G, Maurage P, Cottencin O, Carrieri PM, Rolland B.

Front Pharmacol. 2019 May 31;10:627. doi: 10.3389/fphar.2019.00627. eCollection 2019. Review.

11.

Role of Patient Sex in Early Recovery from Alcohol-Related Cognitive Impairment: Women Penalized.

Luquiens A, Rolland B, Pelletier S, Alarcon R, Donnadieu-Rigole H, Benyamina A, Nalpas B, Perney P.

J Clin Med. 2019 Jun 4;8(6). pii: E790. doi: 10.3390/jcm8060790.

12.

Lower HCV treatment uptake in women who have received opioid agonist therapy before and during the DAA era: The ANRS FANTASIO project.

Rojas Rojas T, Di Beo V, Delorme J, Barre T, Mathurin P, Protopopescu C, Bailly F, Coste M, Authier N, Carrieri MP, Rolland B, Marcellin F.

Int J Drug Policy. 2019 Oct;72:61-68. doi: 10.1016/j.drugpo.2019.05.013. Epub 2019 May 22.

PMID:
31129024
13.

Respective influence of current alcohol consumption and duration of heavy drinking on brain morphological alterations in alcohol use disorder.

Rolland B, Dricot L, Creupelandt C, Maurage P, De Timary P.

Addict Biol. 2019 Apr 9:e12751. doi: 10.1111/adb.12751. [Epub ahead of print]

PMID:
30963660
14.

IPSIM-Web, An Online Resource for Promoting Qualitative Aggregative Hierarchical Network Models to Predict Plant Disease Risk: Application to Brown Rust on Wheat.

Robin MH, Bancal MO, Cellier V, Délos M, Felix I, Launay M, Magnard A, Olivier A, Robert C, Rolland B, Sache I, Aubertot JN.

Plant Dis. 2018 Mar;102(3):488-499. doi: 10.1094/PDIS-12-16-1816-SR. Epub 2017 Nov 21.

PMID:
30673480
15.

The Use of Baclofen as a Treatment for Alcohol Use Disorder: A Clinical Practice Perspective.

de Beaurepaire R, Sinclair JMA, Heydtmann M, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, Leggio L, Agabio R.

Front Psychiatry. 2019 Jan 4;9:708. doi: 10.3389/fpsyt.2018.00708. eCollection 2018. Review.

16.

A Patient-Tailored Evidence-Based Approach for Developing Early Neuropsychological Training Programs in Addiction Settings.

Rolland B, D'Hondt F, Montègue S, Brion M, Peyron E, D'Aviau de Ternay J, de Timary P, Nourredine M, Maurage P.

Neuropsychol Rev. 2019 Mar;29(1):103-115. doi: 10.1007/s11065-018-9395-3. Epub 2019 Jan 3. Review.

PMID:
30607658
17.

Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.

Agabio R, Sinclair JM, Addolorato G, Aubin HJ, Beraha EM, Caputo F, Chick JD, de La Selle P, Franchitto N, Garbutt JC, Haber PS, Heydtmann M, Jaury P, Lingford-Hughes AR, Morley KC, Müller CA, Owens L, Pastor A, Paterson LM, Pélissier F, Rolland B, Stafford A, Thompson A, van den Brink W, de Beaurepaire R, Leggio L.

Lancet Psychiatry. 2018 Dec;5(12):957-960. doi: 10.1016/S2215-0366(18)30303-1. Epub 2018 Nov 6. No abstract available.

18.

Pharmacokinetic Studies of Baclofen Are Not Sufficient to Establish an Optimized Dosage for Management of Alcohol Disorder.

Simon N, Franchitto N, Rolland B.

Front Psychiatry. 2018 Oct 5;9:485. doi: 10.3389/fpsyt.2018.00485. eCollection 2018. Review.

19.

[The serotonin syndrome: An updated literature review].

Jurek L, Nourredine M, Megarbane B, d'Amato T, Dorey JM, Rolland B.

Rev Med Interne. 2019 Feb;40(2):98-104. doi: 10.1016/j.revmed.2018.08.010. Epub 2018 Sep 20. Review. French.

PMID:
30243558
20.

How to Manage Self-Poisoning With Baclofen in Alcohol Use Disorder? Current Updates.

Franchitto N, Rolland B, Pelissier F, Simon N.

Front Psychiatry. 2018 Sep 4;9:417. doi: 10.3389/fpsyt.2018.00417. eCollection 2018. Review.

21.

Full-Profile Pharmacokinetic Study of High Dose Baclofen in Subjects With Alcohol Use Disorder.

Simon N, Moirand R, Dematteis M, Bordet R, Deplanque D, Rolland B.

Front Psychiatry. 2018 Aug 23;9:385. doi: 10.3389/fpsyt.2018.00385. eCollection 2018.

22.

Safety Challenges of Using High Dose Baclofen for Alcohol Use Disorder: A Focused Review.

Rolland B, Simon N, Franchitto N.

Front Psychiatry. 2018 Aug 22;9:367. doi: 10.3389/fpsyt.2018.00367. eCollection 2018. Review.

23.

Psychiatric comorbidities associated with a positive screening using the Montreal Cognitive Assessment (MoCA) test in subjects with severe alcohol use disorder.

D'Hondt F, Lescut C, Maurage P, Menard O, Gibour B, Cottencin O, Montègue S, Jardri R, Rolland B.

Drug Alcohol Depend. 2018 Oct 1;191:266-269. doi: 10.1016/j.drugalcdep.2018.07.009. Epub 2018 Aug 22.

PMID:
30153608
24.

Searching for Survivor-Specific Services at NCI-Designated Comprehensive Cancer Centers: A Qualitative Assessment.

Rolland B, Eschler J.

J Natl Compr Canc Netw. 2018 Jul;16(7):839-844. doi: 10.6004/jnccn.2018.7019.

PMID:
30006426
25.

Animal models of binge drinking, current challenges to improve face validity.

Jeanblanc J, Rolland B, Gierski F, Martinetti MP, Naassila M.

Neurosci Biobehav Rev. 2019 Nov;106:112-121. doi: 10.1016/j.neubiorev.2018.05.002. Epub 2018 May 5. Review.

PMID:
29738795
26.

Influence of comorbid alcohol use disorders on the clinical patterns of major depressive disorder: A general population-based study.

Carton L, Pignon B, Baguet A, Benradia I, Roelandt JL, Vaiva G, Thomas P, Amad A, De Timary P, Naassila M, Geoffroy PA, Rolland B.

Drug Alcohol Depend. 2018 Jun 1;187:40-47. doi: 10.1016/j.drugalcdep.2018.02.009. Epub 2018 Mar 23.

PMID:
29626745
27.

Prevalence and predictors of no lifetime utilization of mental health treatment among people with mental disorders in France: findings from the 'Mental Health in General Population' (MHGP) survey.

Font H, Roelandt JL, Behal H, Geoffroy PA, Pignon B, Amad A, Simioni N, Vaiva G, Thomas P, Duhamel A, Benradia I, Rolland B.

Soc Psychiatry Psychiatr Epidemiol. 2018 Jun;53(6):567-576. doi: 10.1007/s00127-018-1507-0. Epub 2018 Apr 4.

PMID:
29619580
28.

Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study.

Vannimenus C, Bricout H, Le Rouzic O, Mouawad F, Chevalier D, Dansin E, Rotsaert L, Lefebvre G, Cottencin O, Porte H, Scherpereel A, El Fahsi A, Richard F, Rolland B; ALTAK Study Group.

BMC Cancer. 2018 Apr 3;18(1):372. doi: 10.1186/s12885-018-4253-5.

29.

Increased prevalence of anxiety disorders in third-generation migrants in comparison to natives and to first-generation migrants.

Pignon B, Amad A, Pelissolo A, Fovet T, Thomas P, Vaiva G, Roelandt JL, Benradia I, Rolland B, Geoffroy PA.

J Psychiatr Res. 2018 Jul;102:38-43. doi: 10.1016/j.jpsychires.2018.03.007. Epub 2018 Mar 20.

PMID:
29597072
30.

[Consultation/liaison addiction medicine: Tools and specificities].

Poloméni P, Cleirec G, Icard C, Ramos A, Rolland B.

Encephale. 2018 Sep;44(4):354-362. doi: 10.1016/j.encep.2017.12.007. Epub 2018 Mar 24. Review. French.

PMID:
29580705
31.

The need for patient-tailored dosing of baclofen in future clinical trials.

Costa M, Rolland B, Carrieri P.

Eur Neuropsychopharmacol. 2018 May;28(5):656-657. doi: 10.1016/j.euroneuro.2018.03.001. Epub 2018 Mar 16. No abstract available.

PMID:
29551439
32.

[Authors' response].

Rolland B, Authier N, Brousse G, Bouhassira D, Perrot S, Dematteis M.

Rev Med Interne. 2018 Jun;39(6):447-448. doi: 10.1016/j.revmed.2018.02.006. Epub 2018 Mar 8. French. No abstract available.

PMID:
29526326
33.

Evaluation by undergraduate medical students of a role-playing training program on the management of acute states of agitation.

Rolland B, Fovet T, Poissy J, Eichholtzer C, Lesage M, Thomas P, Jourdain M.

Encephale. 2018 Apr;44(2):101-105. doi: 10.1016/j.encep.2017.09.009. Epub 2017 Dec 22.

PMID:
29275981
34.

A latent class analysis of psychotic symptoms in the general population.

Pignon B, Peyre H, Szöke A, Geoffroy PA, Rolland B, Jardri R, Thomas P, Vaiva G, Roelandt JL, Benradia I, Behal H, Schürhoff F, Amad A.

Aust N Z J Psychiatry. 2018 Jun;52(6):573-584. doi: 10.1177/0004867417744255. Epub 2017 Dec 13.

PMID:
29232967
35.

Binge Eating, But Not Other Disordered Eating Symptoms, Is a Significant Contributor of Binge Drinking Severity: Findings from a Cross-Sectional Study among French Students.

Rolland B, Naassila M, Duffau C, Houchi H, Gierski F, André J.

Front Psychol. 2017 Oct 30;8:1878. doi: 10.3389/fpsyg.2017.01878. eCollection 2017.

36.

On-the-ground application of the 'temporary recommendation for use' regulatory measure on off-label use of baclofen for alcohol dependence in France: a regional survey of community pharmacies.

Auffret M, Rolland B, Caous AS, Gaboriau L, Deheul S, Bordet R, Gautier S.

Fundam Clin Pharmacol. 2018 Apr;32(2):234-238. doi: 10.1111/fcp.12332. Epub 2017 Dec 6.

PMID:
29143356
37.

On the Facilitation of Collaborative Research: Enter Stage Left, the Consortium Director.

Rolland B, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1581-1582. doi: 10.1158/1055-9965.EPI-17-0471. No abstract available.

38.

The Role of General Practitioners in the 2015 French Guidelines on Alcohol Misuse.

Rolland B, Naassila M, Paille F, Aubin HJ; Société Française d’Alcoologie.

Alcohol Alcohol. 2017 Nov 1;52(6):747-748. doi: 10.1093/alcalc/agx054. No abstract available.

PMID:
29016709
39.

Thirty- Versus Ten-Day Diazepam Treatment for Alcohol Detoxification and a Comparison of Drinking Patterns, Craving, and Anxiety for up to 12 Weeks: A "Proof-of-Concept" Open-Label Randomized Controlled Trial.

Simioni N, Labreuche J, Behal H, Cottencin O, Rolland B.

J Clin Psychopharmacol. 2017 Dec;37(6):722-728. doi: 10.1097/JCP.0000000000000786.

PMID:
28984747
40.

A study in the general population about sadness to disentangle the continuum from well-being to depressive disorders.

Tebeka S, Pignon B, Amad A, Le Strat Y, Brichant-Petitjean C, Thomas P, Vaiva G, Roelandt JL, Benradia I, Etain B, Rolland B, Dubertret C, Geoffroy PA.

J Affect Disord. 2018 Jan 15;226:66-71. doi: 10.1016/j.jad.2017.08.085. Epub 2017 Sep 21.

PMID:
28963866
41.

Are we ready to treat hepatitis C virus in individuals with opioid use disorder: assessment of readiness in European countries on the basis of an expert-generated model.

Wright N, Reimer J, Somaini L, Roncero C, Maremmani I, Simon N, Krajci P, Littlewood R, D'Agnone O, Alho H, Rolland B.

Eur J Gastroenterol Hepatol. 2017 Nov;29(11):1206-1214. doi: 10.1097/MEG.0000000000000962. Review.

PMID:
28914697
42.

Naltrexone- or Nalmefene-Related Buprenorphine Withdrawal: Treat It With… More Buprenorphine.

Lescut C, Gaboriau L, Carton L, Rolland B.

J Clin Psychopharmacol. 2017 Oct;37(5):631-633. doi: 10.1097/JCP.0000000000000763. No abstract available.

PMID:
28806388
43.

Severity of Baclofen Self-Poisoning Linked to Psychiatric Co-morbidity in Alcohol-Dependent Patients: Better Measurement of Risk and Benefit.

Pelissier F, de Haro L, Rolland B, Franchitto N.

Basic Clin Pharmacol Toxicol. 2017 Oct;121(4):217-219. doi: 10.1111/bcpt.12832. Epub 2017 Jul 10. No abstract available.

44.

Sociodemographic and clinical correlates of psychotic symptoms in the general population: Findings from the MHGP survey.

Pignon B, Schürhoff F, Szöke A, Geoffroy PA, Jardri R, Roelandt JL, Rolland B, Thomas P, Vaiva G, Amad A.

Schizophr Res. 2018 Mar;193:336-342. doi: 10.1016/j.schres.2017.06.053. Epub 2017 Jul 8.

PMID:
28689754
45.

The dose-effect relationship of baclofen in alcohol dependence: A 1-year cohort study.

Pignon B, Labreuche J, Auffret M, Gautier S, Deheul S, Simioni N, Cottencin O, Bordet R, Duhamel A, Rolland B.

Hum Psychopharmacol. 2017 Jul;32(4). doi: 10.1002/hup.2593. Epub 2017 May 18.

PMID:
28517239
46.

Alcohol Use Disorders and Immigration up to the Third Generation in France: Findings from a 39,617-Subject Survey in the General Population.

Rolland B, Geoffroy PA, Pignon B, Benradia I, Font H, Roelandt JL, Amad A.

Alcohol Clin Exp Res. 2017 Jun;41(6):1137-1143. doi: 10.1111/acer.13387. Epub 2017 May 2.

PMID:
28470666
47.

Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: A prospective study.

Louvet A, Labreuche J, Artru F, Bouthors A, Rolland B, Saffers P, Lollivier J, Lemaître E, Dharancy S, Lassailly G, Canva-Delcambre V, Duhamel A, Mathurin P.

Hepatology. 2017 Nov;66(5):1464-1473. doi: 10.1002/hep.29240. Epub 2017 Sep 26.

PMID:
28459138
48.

Comparison between the WHO and NIAAA criteria for binge drinking on drinking features and alcohol-related aftermaths: Results from a cross-sectional study among eight emergency wards in France.

Rolland B, Chazeron I, Carpentier F, Moustafa F, Viallon A, Jacob X, Lesage P, Ragonnet D, Genty A, Geneste J, Poulet E, Dematteis M, Llorca PM, Naassila M, Brousse G.

Drug Alcohol Depend. 2017 Jun 1;175:92-98. doi: 10.1016/j.drugalcdep.2017.01.034. Epub 2017 Mar 23.

PMID:
28411560
49.

Management of precipitated opiate withdrawal syndrome induced by nalmefene mistakenly prescribed in opiate-dependent patients: a review for clinicians.

Franchitto N, Jullian B, Salles J, Pelissier F, Rolland B.

Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):669-677. doi: 10.1080/17425255.2017.1312340. Epub 2017 Apr 3. Review.

PMID:
28343423
50.

[Misuse and dependence on prescription opioids: Prevention, identification and treatment].

Rolland B, Bouhassira D, Authier N, Auriacombe M, Martinez V, Polomeni P, Brousse G, Schwan R, Lack P, Bachellier J, Rostaing S, Bendimerad P, Vergne-Salle P, Dematteis M, Perrot S.

Rev Med Interne. 2017 Aug;38(8):539-546. doi: 10.1016/j.revmed.2016.12.024. Epub 2017 Feb 15. Review. French.

PMID:
28214183

Supplemental Content

Loading ...
Support Center